Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06130592 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound

Study acronym: FetUS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jan 1, 2025 to Nov 30, 2026
    • Start date changed from estimate of Jan 1, 2024 to May 12, 2024
    • Study sites: 0 to 2
    • Study completion date: Feb 1, 2025 to Dec 31, 2026
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to evaluate the performance of muscle ultrasound sections on antenatal ultrasound between 21-24 amenorrhea weeks for the screening of muscle atrophy, in a sample of low-risk and high-risk pregnancies of congenital multiple arthrogryposis
Trial Details
NCT Number NCT06130592
Lead Sponsor University Hospital, Grenoble
Conditions
(from sponsor)		 Arthrogryposis Multiplex Congenita (AMC)
Related terms Arthrogryposis
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov